Browsing: Wegovy

Novo Nordisk NVO received a meaningful commercial boost last week after the European Commission approved the oral version of Wegovy (semaglutide 25 mg) for adults with obesity and at least one weight-related comorbidity. The approval expands the company’s obesity franchise across Europe, making Wegovy the first GLP-1 tablet approved for weight management in the EU and…

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below

New research suggests that a class of medications originally designed to treat type 2 diabetes and aid weight loss may also help reduce binge eating behaviors in people with obesity

Semaglutide and other GLP-1 drugs have exploded in popularity in recent years, primarily due to their ability to help patients lose weight. These drugs are also starting to be used more and more to reduce cardiovascular risks, but questions remain about how, exactly, patients can achieve the best possible benefit. A new analysis in npj…

(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)

Novo Nordisk NVO received a boost after the European Commission (EC) approved once-daily oral version of Wegovy (semaglutide 25 mg) for the treatment of adults with obesity, with at least one weight-related comorbidity, alongside a reduced-calorie diet and increased physical activity

The Wegovy pill contains semaglutide 25 mg and is taken once daily. The approval is based on the OASIS programme, including the OASIS 4 study in 307 adults with obesity or overweight and at least one weight-related comorbidity. The study demonstrated a mean weight loss of 17 per cent compared with 3 per cent for…

July 15 (Reuters) – Novo Nordisk said on Wednesday the European Commission approved its once-daily Wegovy pill for weight management in adults with obesity or who are overweight, making it the first oral GLP-1 weight-loss treatment cleared for use across the European Union

The approval makes Wegovy the first GLP-1 receptor agonist available in tablet form for weight management across all European Union member states

[Sportschosun, Reporter Kim Soo-hyun] Broadcaster Kim So-young drew attention after sharing an update on her rapid weight loss following the birth of her second child